tradingkey.logo
tradingkey.logo
検索

AVITA Medical Inc

RCEL
ウォッチリストに追加
5.060USD
+0.390+8.35%
終値 07/02, 13:00ET15分遅れの株価
778.65M時価総額
損失額直近12ヶ月PER

詳細情報 AVITA Medical Inc 企業名

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

AVITA Medical Incの企業情報

企業コードRCEL
会社名AVITA Medical Inc
上場日Mar 18, 2012
最高経営責任者「CEO」Vance (Cary G)
従業員数260
証券種類Ordinary Share
決算期末Mar 18
本社所在地28159 Avenue Stanford
都市VALENCIA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号91355
電話番号16613679170
ウェブサイトhttps://www.avitamedical.com/
企業コードRCEL
上場日Mar 18, 2012
最高経営責任者「CEO」Vance (Cary G)

AVITA Medical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

よくある質問

AVITA Medical Incの上位5名の株主は誰ですか?

AVITA Medical Incの上位5名の株主は以下のとおりです。Prof. Suzanne Crowe

AVITA Medical Inc(RCEL)の株式を保有している機関の数はいくつですか?

2026Q1時点で、AVITA Medical Incの株式を保有している機関は209社あり、保有株式の総市場価値は約6.52Mで、全体の21.20%を占めています。2025Q4と比較して、機関の持ち株は-1392153.00増加しています。